Colinz Laboratories Q2 Results

  • BSE: 531210
  • NSE: -
  • ISIN: INE923C01011
  • Sector: Biotechnology & Drugs
BSE
53.5-1.52 (-2.76%)
Volume1.88 K
Updated: Mon 25 Nov, 2024 | 15:22:52
NSE
This stock is not traded on NSE
Today: 52.27
55.02
52-Wk: 36.00
84.40

Q2 Results Highlights

  • Total Income
    ₹1.86 Cr.
    (6.67%)
  • Operating Profit
    ₹0.14 Cr.
    (12.15%)
  • Profit After Tax
    ₹0.16 Cr.
    (13.48%)
  • Operating Margin
    7.63%
    (44.93%)
Note: Comparison is on YoY basis

Quarterly - Colinz Laboratories Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 1.861.90-%1.79-%
Selling/ General/ Admin Expenses Total 0.730.79-%0.80-%
Depreciation/ Amortization 0.030.03-%0.03-%
Other Operating Expenses Total 0.400.36-%0.28-%
Total Operating Expense 1.721.78-%1.69-%
Operating Income 0.140.12-%0.09-%
Net Income Before Taxes 0.210.15-%0.16-%
Net Income 0.160.12-%0.12-%
Diluted Normalized EPS 0.620.48-%0.49-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts